Insider Transactions in Q1 2021 at Harvard Bioscience Inc (HBIO)
Insider Transaction List (Q1 2021)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Mar 23
2021
|
John F Kennedy Director |
SELL
Bona fide gift
|
Direct |
6,895
-2.09%
|
-
|
Mar 17
2021
|
John F Kennedy Director |
SELL
Bona fide gift
|
Direct |
12,500
-1.84%
|
-
|
Mar 12
2021
|
James W Green Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
35,000
-1.51%
|
$175,000
$5.98 P/Share
|
Mar 01
2021
|
Kenneth Fletcher Olson Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
64,258
+19.34%
|
-
|
Mar 01
2021
|
Michael A. Rossi Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
75,338
+15.68%
|
-
|
Mar 01
2021
|
James W Green Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
381,372
+7.92%
|
-
|
Jan 04
2021
|
Katherine A. Eade Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,200
+7.2%
|
-
|
Jan 04
2021
|
Alan I Edrick Director |
BUY
Grant, award, or other acquisition
|
Direct |
16,300
+12.33%
|
-
|
Jan 04
2021
|
John F Kennedy Director |
BUY
Grant, award, or other acquisition
|
Direct |
13,200
+3.71%
|
-
|
Jan 04
2021
|
Thomas W Loewald Director |
BUY
Grant, award, or other acquisition
|
Direct |
15,300
+8.38%
|
-
|
Jan 04
2021
|
Bertrand Loy Director |
BUY
Grant, award, or other acquisition
|
Direct |
21,300
+7.25%
|
-
|
Jan 04
2021
|
Susan M. Steele Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,800
+17.94%
|
-
|
Jan 01
2021
|
James W Green Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
30,478
-1.55%
|
$121,912
$4.29 P/Share
|